Floatz logo

ipn10200

Chronic Migraine

IpsenPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Chronic Migraine cohort.

Asset / SponsorPhaseRating
Pregabalin
Taipei Veterans General Hospital, Taiwan
Phase 4BB
Galcanezumab
Beth Israel Deaconess Medical Center
Phase 4BB
Onabotulinum Toxin A
University of Alberta
Phase 4BB
BETAMETHASONE
Jakob Møller Hansen, MD.
Phase 4BB
PROPRANOLOL
Anne Lindblad
Phase 3B

View all 15 →

Same molecule, other indications

ipn10200 is also rated in:

migraine disorderDormant
CCC
Indicative ·
53 / 100
View asset →
SpasticityDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →